{"@context":["https://w3id.org/dats/context/sdo/dataset_sdo_context.jsonld","http://w3id.org/dats/context/obo/dataset_obo_context.jsonld"],"@type":"Project","acronym":"EBOVAC2","description":"Development of a prophylactic Ebola vaccine using an heterologous prime-boost regimen: phase II","endDate":{"@context":"https://w3id.org/dats/context/sdo/date_info_sdo_context.jsonld","@type":"Date","date":"Mon, 31 May 2021 00:00:00 GMT","type":{"value":"end date","valueIRI":"http://semanticscience.org/resource/SIO_000036"}},"extraProperties":[{"category":"website","values":[{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"http://www.ebovac2.com/"}]}],"fundedBy":[{"@context":"https://w3id.org/dats/context/sdo/grant_sdo_context.jsonld","@type":"Grant","name":"IMI2 - Call 2 (Grant number 115861)"}],"identifier":{"@context":"https://w3id.org/dats/context/sdo/identifier_info_sdo_context.jsonld","@type":"Identifier","identifier":"f04cc090-5f11-11eb-917b-acde48001122"},"keywords":[{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"IMI projects"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Infectious diseases"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Ebola and related diseases"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Vaccines"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Ebola+"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Conducting clinical trials"}],"projectAssets":[],"projectLeads":[{"@context":"https://w3id.org/dats/context/sdo/person_sdo_context.jsonld","@type":"Person","affiliations":[{"@context":"https://w3id.org/dats/context/sdo/organization_sdo_context.jsonld","@type":"Organization","location":{"@context":"https://w3id.org/dats/context/sdo/place_sdo_context.jsonld","@type":"Place","postalAddress":"The Netherlands"},"name":"Janssen Vaccines & Prevention B.V"}],"email":"-","firstName":"Macaya","fullName":"Macaya Douoguih","lastName":"Douoguih","roles":[{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Project leader"}]}],"projectWebsite":"http://www.ebovac2.com/","startDate":{"@context":"https://w3id.org/dats/context/sdo/date_info_sdo_context.jsonld","@type":"Date","date":"Mon, 01 Dec 2014 00:00:00 GMT","type":{"value":"start date","valueIRI":"http://semanticscience.org/resource/SIO_000031"}},"title":"EBOVAC2","types":[{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"IMI projects"}]}